Advances in the Treatment of HIV: Focus on Newer Strategies

In this presentation, Dr. Andrew Zolopa, Professor Emeritus of Medicine at Stanford School of Medicine, discusses the history of antiretroviral therapy (ART) in HIV-infected patients. He highlights some of the potential long-term risks of ART regimens in this patient population. Dr. Zolopa describes the recent advances in the treatment of HIV-infected patients, such as two-drug regimens which have been included in clinical guidelines, and long-acting injectable drugs that are being evaluated in clinical trials.

In the second part of his presentation, Dr. Zolopa examines the different strategies and challenges of treating viral suppressed HIV-infected patients versus treatment-naïve patients. 

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Andrew Zolopa, M.D.

    Andrew Zolopa, M.D.

    Professor Emeritus
    Stanford University School of Medicine

    Disclosure:

    Nothing to disclose.